GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting

MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL will present new data on its Methylation Platform and the impact of MCED testing in guiding diagnostic evaluation at the AACR Annual Meeting.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks